Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
Debio 1142
print preview
bookmark
share with colleague
General Information
Company
Debiopharm Group
Description
Cancer pathway inhibitor
Molecular Target
Mechanism of Action
Latest Stage of Development
Discovery
Indication
Solid tumors
Partner
Aurigene Discovery Technologies Ltd.
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy